Analysis of dosing strategies for secondary prophylaxis for prevention of Cytomegalovirus (CMV) recurrence in solid organ transplantation

被引：0
|
作者：
Roshdy, Danya [1 ]
Baker, Cassandra [1 ]
Dupuis, Robert [2 ]
Deyo, Jennifer [3 ]
Lee, RuthAnn M. [2 ]
机构：
[1] Univ N Carolina Hosp, Sch Pharm, Dept Pharm, Chapel Hill, NC USA
[2] UNC Eshelman Sch Pharm, Chapel Hill, NC USA
[3] Univ N Carolina, Mem Hosp, Dept Pharm, Chapel Hill, NC USA
来源：
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
292
引用
收藏
页码：E270 / E270
页数：1
相关论文
共 50 条
  • [41] Cytomegalovirus Prevention Strategies: The Case for Prophylaxis
    Snydman, D. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (05) : 1254 - 1254
  • [42] Cytomegalovirus disease following liver transplantation: an analysis of prophylaxis strategies
    Singhal, S
    Khan, OA
    Bramble, RA
    Mutimer, DJ
    JOURNAL OF INFECTION, 2003, 47 (02) : 104 - 109
  • [43] GANCICLOVIR SUSCEPTIBILITIES OF CYTOMEGALOVIRUS (CMV) ISOLATES FROM SOLID-ORGAN TRANSPLANT RECIPIENTS WITH CMV VIREMIA AFTER ANTIVIRAL PROPHYLAXIS
    BOIVIN, G
    ERICE, A
    CRANE, DD
    DUNN, DL
    BALFOUR, HH
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02): : 332 - 335
  • [44] Cytomegalovirus prophylaxis in solid organ transplant recipients
    Patel, R
    Snydman, DR
    Rubin, RH
    Ho, M
    Pescovitz, M
    Martin, M
    Paya, CV
    TRANSPLANTATION, 1996, 61 (09) : 1279 - 1289
  • [45] Prevention of Cytomegalovirus (CMV) Infection by Valganciclovir (VGCV) in Solid Organ Transplant Recipients: The Orval Study
    Legendre, C.
    Saliba, R.
    Fourrier-Reglat, A.
    Nguyen, L.
    Tagieva, N.
    Guillemain, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 457 - 457
  • [46] Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis
    Saullo, Jennifer L.
    Baker, Arthur W.
    Snyder, Laurie D.
    Reynolds, John M.
    Zaffiri, Lorenzo
    Eichenberger, Emily M.
    Ferrari, Alana
    Steinbrink, Julie M.
    Maziarz, Eileen K.
    Bacchus, Melissa
    Berry, Holly
    Kakoullis, Stylianos A.
    Wolfe, Cameron R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : 508 - 515
  • [47] PREVENTION OF CYTOMEGALOVIRUS (CMV) INFECTION BY VALGANCICLOVIR (VGCV) IN SOLID ORGAN TRANSPLANT RECIPIENTS: THE ORVAL STUDY
    Legendre, C.
    Guillemain, R.
    Fourrier-Reglat, A.
    Nguyen, L.
    Tagieva, N.
    Saliba, F.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 174 - 174
  • [48] CYTOMEGALOVIRUS (CMV) PROPHYLAXIS FOLLOWING LIVER-TRANSPLANTATION (LTX)
    DICKSON, RC
    PORAYKO, MK
    KEATING, MR
    PAYA, CV
    WILHELM, MP
    WALKER, R
    GORES, GJ
    HAY, JE
    RAKELA, J
    KROM, RAF
    WIESNER, RH
    HEPATOLOGY, 1992, 16 (04) : A277 - A277
  • [49] Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
    Lodding, I. P.
    Bang, C. da Cunha
    Sorensen, S. S.
    Gustafsson, F.
    Iversen, M.
    Kirkby, N.
    Perch, M.
    Rasmussen, A.
    Sengelov, H.
    Mocroft, A.
    Lundgren, J. D.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (05):
  • [50] Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation: Effective CMV prevention following daclizumab induction
    Weill, D
    Lock, BJ
    Wewers, DL
    Young, KR
    Zorn, GL
    Early, L
    Kirklin, JK
    McGiffin, DC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (04) : 492 - 496
12345